Antimicrobial therapy in palliative care: an overview

Area of Science:

• Palliative Care Medicine
• Infectious Diseases
• Medical Ethics

Background:

• Terminally ill patients frequently experience infections, complicating advanced care planning.
• Antimicrobial therapy in palliative care poses significant ethical dilemmas for clinicians.
• Decisions regarding treatment, withholding, or withdrawal of antimicrobials require careful consideration.

Purpose of the Study:

• To characterize common infections, causative agents, and treatment strategies in palliative care settings.
• To explore the ethical considerations surrounding antimicrobial use in terminally ill patients.
• To provide guidance for healthcare professionals on clinical decision-making for antimicrobial therapy.

Main Methods:

• A comprehensive review of existing literature on infections and antimicrobial use in palliative care was conducted.
• Analysis focused on identifying patterns of infection, prevalent antimicrobial agents, and treatment outcomes.
• Clinical decision-making frameworks and ethical considerations were synthesized from the reviewed studies.

Main Results:

• Antimicrobial administration offers potential benefits such as prolonged survival and symptom relief.
• However, antimicrobial use can also lead to adverse outcomes, necessitating a balanced approach.
• Decisions regarding antibiotherapy are often more complex than withholding other life-sustaining treatments.

Conclusions:

• Antimicrobial therapy in palliative care requires a nuanced approach, weighing benefits against risks.
• Clinical guidelines and ethical frameworks are essential to support healthcare professionals in these complex decisions.
• Further research can refine best practices for managing infections in terminally ill patients.